Cargando…

Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility

The promising potential of superparamagnetic iron oxide nanoparticles (SPIONs) in various nanomedical applications has been frequently reported. However, although many different synthesis methods, coatings, and functionalization techniques have been described, not many core-shell SPION drug delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaloga, Jan, Janko, Christina, Nowak, Johannes, Matuszak, Jasmin, Knaup, Sabine, Eberbeck, Dietmar, Tietze, Rainer, Unterweger, Harald, Friedrich, Ralf P, Duerr, Stephan, Heimke-Brinck, Ralph, Baum, Eva, Cicha, Iwona, Dörje, Frank, Odenbach, Stefan, Lyer, Stefan, Lee, Geoffrey, Alexiou, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211907/
https://www.ncbi.nlm.nih.gov/pubmed/25364244
http://dx.doi.org/10.2147/IJN.S68539
_version_ 1782341636740612096
author Zaloga, Jan
Janko, Christina
Nowak, Johannes
Matuszak, Jasmin
Knaup, Sabine
Eberbeck, Dietmar
Tietze, Rainer
Unterweger, Harald
Friedrich, Ralf P
Duerr, Stephan
Heimke-Brinck, Ralph
Baum, Eva
Cicha, Iwona
Dörje, Frank
Odenbach, Stefan
Lyer, Stefan
Lee, Geoffrey
Alexiou, Christoph
author_facet Zaloga, Jan
Janko, Christina
Nowak, Johannes
Matuszak, Jasmin
Knaup, Sabine
Eberbeck, Dietmar
Tietze, Rainer
Unterweger, Harald
Friedrich, Ralf P
Duerr, Stephan
Heimke-Brinck, Ralph
Baum, Eva
Cicha, Iwona
Dörje, Frank
Odenbach, Stefan
Lyer, Stefan
Lee, Geoffrey
Alexiou, Christoph
author_sort Zaloga, Jan
collection PubMed
description The promising potential of superparamagnetic iron oxide nanoparticles (SPIONs) in various nanomedical applications has been frequently reported. However, although many different synthesis methods, coatings, and functionalization techniques have been described, not many core-shell SPION drug delivery systems are available for clinicians at the moment. Here, bovine serum albumin was adsorbed onto lauric acid-stabilized SPIONs. The agglomeration behavior, zeta potential, and their dependence on the synthesis conditions were characterized with dynamic light scattering. The existence and composition of the core-shell-matrix structure was investigated by transmission electron microscopy, Fourier transform infrared spectroscopy, and zeta potential measurements. We showed that the iron oxide cores form agglomerates in the range of 80 nm. Moreover, despite their remarkably low tendency to aggregate even in a complex media like whole blood, the SPIONs still maintained their magnetic properties and were well attractable with a magnet. The magnetic properties were quantified by vibrating sample magnetometry and a superconducting quantum interference device. Using flow cytometry, we further investigated the effects of the different types of nanoparticle coating on morphology, viability, and DNA integrity of Jurkat cells. We showed that by addition of bovine serum albumin, the toxicity of nanoparticles is greatly reduced. We also investigated the effect of the particles on the growth of primary human endothelial cells to further demonstrate the biocompatibility of the particles. As proof of principle, we showed that the hybrid-coated particles are able to carry payloads of up to 800 μg/mL of the cytostatic drug mitoxantrone while still staying colloidally stable. The drug-loaded system exhibited excellent therapeutic potential in vitro, exceeding that of free mitoxantrone. In conclusion, we have synthesized a biocompatible ferrofluid that shows great potential for clinical application. The synthesis is straightforward and reproducible and thus easily translatable into a good manufacturing practice environment.
format Online
Article
Text
id pubmed-4211907
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42119072014-10-31 Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility Zaloga, Jan Janko, Christina Nowak, Johannes Matuszak, Jasmin Knaup, Sabine Eberbeck, Dietmar Tietze, Rainer Unterweger, Harald Friedrich, Ralf P Duerr, Stephan Heimke-Brinck, Ralph Baum, Eva Cicha, Iwona Dörje, Frank Odenbach, Stefan Lyer, Stefan Lee, Geoffrey Alexiou, Christoph Int J Nanomedicine Original Research The promising potential of superparamagnetic iron oxide nanoparticles (SPIONs) in various nanomedical applications has been frequently reported. However, although many different synthesis methods, coatings, and functionalization techniques have been described, not many core-shell SPION drug delivery systems are available for clinicians at the moment. Here, bovine serum albumin was adsorbed onto lauric acid-stabilized SPIONs. The agglomeration behavior, zeta potential, and their dependence on the synthesis conditions were characterized with dynamic light scattering. The existence and composition of the core-shell-matrix structure was investigated by transmission electron microscopy, Fourier transform infrared spectroscopy, and zeta potential measurements. We showed that the iron oxide cores form agglomerates in the range of 80 nm. Moreover, despite their remarkably low tendency to aggregate even in a complex media like whole blood, the SPIONs still maintained their magnetic properties and were well attractable with a magnet. The magnetic properties were quantified by vibrating sample magnetometry and a superconducting quantum interference device. Using flow cytometry, we further investigated the effects of the different types of nanoparticle coating on morphology, viability, and DNA integrity of Jurkat cells. We showed that by addition of bovine serum albumin, the toxicity of nanoparticles is greatly reduced. We also investigated the effect of the particles on the growth of primary human endothelial cells to further demonstrate the biocompatibility of the particles. As proof of principle, we showed that the hybrid-coated particles are able to carry payloads of up to 800 μg/mL of the cytostatic drug mitoxantrone while still staying colloidally stable. The drug-loaded system exhibited excellent therapeutic potential in vitro, exceeding that of free mitoxantrone. In conclusion, we have synthesized a biocompatible ferrofluid that shows great potential for clinical application. The synthesis is straightforward and reproducible and thus easily translatable into a good manufacturing practice environment. Dove Medical Press 2014-10-20 /pmc/articles/PMC4211907/ /pubmed/25364244 http://dx.doi.org/10.2147/IJN.S68539 Text en © 2014 Zaloga et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zaloga, Jan
Janko, Christina
Nowak, Johannes
Matuszak, Jasmin
Knaup, Sabine
Eberbeck, Dietmar
Tietze, Rainer
Unterweger, Harald
Friedrich, Ralf P
Duerr, Stephan
Heimke-Brinck, Ralph
Baum, Eva
Cicha, Iwona
Dörje, Frank
Odenbach, Stefan
Lyer, Stefan
Lee, Geoffrey
Alexiou, Christoph
Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
title Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
title_full Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
title_fullStr Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
title_full_unstemmed Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
title_short Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
title_sort development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211907/
https://www.ncbi.nlm.nih.gov/pubmed/25364244
http://dx.doi.org/10.2147/IJN.S68539
work_keys_str_mv AT zalogajan developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT jankochristina developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT nowakjohannes developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT matuszakjasmin developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT knaupsabine developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT eberbeckdietmar developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT tietzerainer developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT unterwegerharald developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT friedrichralfp developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT duerrstephan developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT heimkebrinckralph developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT baumeva developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT cichaiwona developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT dorjefrank developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT odenbachstefan developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT lyerstefan developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT leegeoffrey developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility
AT alexiouchristoph developmentofalauricacidalbuminhybridironoxidenanoparticlesystemwithimprovedbiocompatibility